5 July 2018

Linda Rainey, Mireille Broeders, Daniëlle van der Waal, and colleagues published three papers last month on the future implementation of risk-based breast cancer screening and prevention.

Increased knowledge of breast cancer risk factors provides an opportunity to shift from one-size-fits-all screening to a personalised approach, establishing screening and prevention policy based on women’s individual risk of developing breast cancer. Potential implementation of  this new paradigm is likely to present considerable challenges, and requires the support from eligible women to facilitate uptake. 

Our systematic review of women’s perceptions showed that women carefully review their perceived susceptibility to breast cancer when considering the adoption of this novel screening and prevention programme. Their decisions about participation are based on a cost-benefit analysis of adopting tailored screening, risk-reducing medication, lifestyle changes, and/or prophylactic surgery, whilst taking into account their own perceived competence, autonomy, relatedness to others, and personal preference. 

To obtain further insights on acceptability, we performed a mixed-methods study with healthcare professionals from the Netherlands, Sweden, and the United Kingdom who identified five themes that could impact women’s decision-making: (1) Anxiety/worry, (2) Proactive approach, (3) Reassurance, (4) Lack of knowledge, and (5) Organisation of risk assessment and feedback. Dutch and British professionals specifically expressed concerns about the acceptability of a heterogeneous screening policy, suggesting women will question their risk feedback and assigned pathway of care. Swedish professionals emphasised the potential impact on family relations.

Our review of future organisational implications of introducing risk-based breast cancer screening and prevention shows that significant changes in policy and practice are warranted. Feasibility of implementation depends on how healthcare is funded and arranged, and potentially varies between countries. Pilot studies of risk assessment and prevention counselling in primary care settings have highlighted a need for extensive additional training on risk (communication) and prevention, the impact on workflow, and professionals' personal discomfort breaching the topic with women. Additionally, gaps in risk estimation, psychological, ethical and legal consequences will need to be addressed.

Publications
Women's perceptions of the adoption of personalised risk-based breast cancer screening and primary prevention: a systematic review.
Rainey L, van der Waal D, Wengström Y, Jervaeus A, Broeders MJM.

Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
Rainey L, van der Waal D, Donnelly LS, Evans DG, Wengström Y, Broeders M.

Are we ready for the challenge of implementing risk-based breast cancer screening and primary prevention?
Rainey L, van der Waal D, Jervaeus A, Wengström Y, Evans DG, Donnelly LS, Broeders MJM.


Linda Rainey, Mireille Broeders, and Daniëlle van der Waal are all members of theme Women’s cancers

Related news items


650,000 Euro funding for research into the phasing out of medication for leukaemia patients

30 July 2020

With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.

read more

Increased role of patients after bowel cancer treatment

30 July 2020

Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.

read more

Hypatia fellowship Call is open

30 July 2020

The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.  

read more

Mihai Netea and colleagues published two papers back-to-back in The Journal of Clinical Investigation. 

29 July 2020

These back-to-back articles investigated the effect of BCG vaccination on trained immunity. The first article shows that BCG vaccination inhibits systemic inflammation, depending on gender. The second article demonstrates that the circadian rhythm influences the induction of trained immunity.

read more

Improved method for detecting lung cancer

24 July 2020

Radboudumc researchers are the only ones in the Netherlands using a new method to make better lung cancer diagnoses earlier stage. Erik van der Heijden and Roel Verhoeven shows that the use of flexible imaging equipment via the natural respiratory tract contributes to a more accurate diagnosis.

read more

Optimizing workup in head and neck cancer (HNC)

23 July 2020

In the journal Cancer RIHS researcher Henrieke Schutte described the outcomes after the implementation of a fast-track multidisciplinary integrated HNC care program: time-to-treatment was significantly reduced and survival and patient satisfaction increased significantly without increasing costs.

read more